Results 101 to 110 of about 762,366 (142)

Considering homologous recombination deficiency status in HIPEC: could molecular testing someday drive "targeted" surgery? [PDF]

Gynecol Oncol Rep
Huepenbecker SP, Fuh KC.
europepmc   +1 more source

Prevalence of Homologous Recombination Deficiency and Treatment Patterns in Patients with Newly Diagnosed Advanced Ovarian Cancer in Bulgaria: A Real-World Cohort Study (VALIDATE). [PDF]

Medicina (Kaunas)
Arabadjiev J, Nikolov K, Koleva M, Shopov N, Tonev I, Krasteva R, Donev I, Yordanov V, Minchev V, Konsoulova A.   +9 more
europepmc   +1 more source

Homologous Recombination Deficiency Testing in Women With Ovarian Cancer: An Egyptian Multicentre Study. [PDF]

BJOG
Shohdy KS, Kassem L, Gabriel B, Barsoum E, Elnahas T, Azim HA.   +5 more
europepmc   +1 more source

Functional footprints of homologous recombination deficiency in prostate cancer revealed by ctDNA fragmentation and transcription factor accessibility. [PDF]

Br J Cancer
Vlachos G, Moser T, Lazzeri I, Moser MJ, Glawitch L, Bauernhofer ET, Eberhard A, Beichler C, Sadeghi H, Blatterer J, Kühberger S, Monsberger N, Terbuch A, Kashofer K, Geigl JB, Bauernhofer T, Heitzer E.   +16 more
europepmc   +1 more source

Analytical validation of a homologous recombination deficiency signature (HRDsig) in pan-tumor tissue samples. [PDF]

PLoS One
Li W, Leibowitz JA, Wang S, Walker L, Xu C, Chen KT, Schrock AB, Hughes J, Patel N, Elvin JA, Ritterhouse LL, Sokol E, Frampton G, Dennis L, Yilmazel B, Decker B.   +15 more
europepmc   +1 more source

Predicting homologous recombination deficiency and treatment responses using a computed tomography-based foundation model: a preclinical study. [PDF]

NPJ Precis Oncol
Kuang S, Schuitmaker L, Wu M, Salahuddin Z, van der Wiel A, van de Laak J, Lieuwes N, Biemans R, Jung J, Yaromina A, Dubois LJ, Woodruff HC, Lambin P.   +12 more
europepmc   +1 more source

The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic Opportunities. [PDF]

Curr Oncol
Bongiovanni A, Conte P, Conteduca V, Landriscina M, Di Lorenzo G, Cognetti F.   +5 more
europepmc   +1 more source

Comparison of MR Imaging of High-grade Serous Carcinomas with and without Homologous Recombination-deficiency. [PDF]

Magn Reson Med Sci
Saida T, Shikama A, Yoshida M, Amano T, Ishiguro T, Sakai M, Hoshiai S, Satoh T, Nakajima T.   +8 more
europepmc   +1 more source

Homologous recombination deficiency in high-grade serous ovarian carcinoma: clinical pathological characteristics, impact of neoadjuvant chemotherapy, and prognostic implications. [PDF]

J Gynecol Oncol
Ge Y, He Y, Yu S, Gao H, Sun PL.
europepmc   +1 more source

The prognostic and predictive value of homologous recombination deficiency in gastrointestinal cancer. [PDF]

Oncologist
Jiang B, Shang Y, Zhang X, He W, Hua H, Ye F, Zhou X, Li Y, Zhong W, Jiang W, Wu G.   +10 more
europepmc   +1 more source